SCHEMBL8618873

SCHEMBL8618873

CN(C)CCCc1ccc2c(c1)N(C(=O)Nc1ccc(-c3ccncc3)c3ccccc13)CC2

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.57
HTR1D P28221 1/20 0.57
HTR1B P28222 1/20 0.57
USP2 O75604 1/20 0.41
HTR2C P28335 11/20 0.40
HTR2A P28223 7/20 0.40
ROCK1 Q13464 1/20 0.40
MAPT P10636 2/20 0.39
HTR2B P41595 3/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
NFKB1 P19838 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
ROCK2 O75116 1/20 0.38
SLC6A4 P31645 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8613884 0.86 HTR1A (0.59) HTR1AHTR1DHTR1BUSP2HTR2C
SCHEMBL8613994 0.86 HTR1A (0.57) HTR1AHTR1DHTR1BUSP2HTR2C
SCHEMBL8615003 0.86 HTR1A (0.66) HTR1AHTR1DHTR1BHTR2CHTR2A
SCHEMBL8617369 0.79 HTR1D (0.59) HTR1AHTR1DHTR1BHTR2CHTR2A
SCHEMBL8614116 0.79 HTR1D (0.57) HTR1AHTR1DHTR1BHTR2CHTR2A
SCHEMBL8616138 0.79 HTR1D (0.57) HTR1AHTR1DHTR1BHTR2CHTR2A
SCHEMBL8617984 0.79 HTR1D (0.65) HTR1AHTR1DHTR1BHTR2CHTR2A
SCHEMBL8128007 0.74 HTR1A (0.79) HTR1AHTR1DHTR1BUSP2HTR2C
SCHEMBL8619486 0.74 HTR1D (0.51) HTR1AHTR1DHTR1BHTR2CHTR2A
SCHEMBL8119474 0.74 HTR1A (0.82) HTR1AHTR1DHTR1BUSP2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998050346-A2 ACETAMIDE AND UREA DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1998-11-12 WO disclosed